StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.35+0.04 (+0.48%)

Close on Nov 17, 2026Market cap $524.94MP/E –Yield –

Electra Therapeutics total assets

Total assets on the balance sheet at the end of each period.

Electra Therapeutics's total assets was $410.82M at Sep 30, 2026. For fiscal 2025 it was $99.37M.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$99.37M–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$410.82M–
Q4 FY2025Dec 31, 2025$99.37M–

More Electra Therapeutics figures

See a number that looks wrong?